Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1

Interventions

Peripheral Blood Stem Cell Transplantation 21Mycophenolic Acid 16Cyclophosphamide 14fludarabine phosphate 13Tacrolimus 13Cyclosporine 13Whole-Body Irradiation 12Therapeutics 8Flow Cytometry 8Filgrastim 8Radiotherapy 7Psychiatric Rehabilitation 7Methylprednisolone 7Methotrexate 7Busulfan 7Antilymphocyte Serum 7Polymerase Chain Reaction 6Rituximab 4Ondansetron 4Etoposide 4Cord Blood Stem Cell Transplantation 4Transplantation 3Sirolimus 3Melphalan 3Interferon-alpha 3Granulocyte Colony-Stimulating Factor 3Early Intervention, Educational 3Bortezomib 3Aprepitant 3Amplified Fragment Length Polymorphism Analysis 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × ON 01910 × Plasma cell × Clear all
NCT00861510 2019-12-03

A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
16 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Hairy Cell, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡